Jerry Bagel, John Nia, Peter W. Hashim, Manmath Patekar, Ana de Vera, Sophie Hugot, . . . Mark Lebwohl. (2018). Secukinumab is Superior to Ustekinumab in Clearing Skin in Patients with Moderate to Severe Plaque Psoriasis (16-Week CLARITY Results). Adis, Springer Healthcare.
Chicago Style (17th ed.) CitationJerry Bagel, et al. Secukinumab Is Superior to Ustekinumab in Clearing Skin in Patients with Moderate to Severe Plaque Psoriasis (16-Week CLARITY Results). Adis, Springer Healthcare, 2018.
MLA (9th ed.) CitationJerry Bagel, et al. Secukinumab Is Superior to Ustekinumab in Clearing Skin in Patients with Moderate to Severe Plaque Psoriasis (16-Week CLARITY Results). Adis, Springer Healthcare, 2018.
Warning: These citations may not always be 100% accurate.